Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0359 in Chronic Obstructive Pulmonary Disease
NCT00482235Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2002
- Primary completion
- Apr 2003
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of MK-0359 in chronic obstructive pulmonary disease (COPD), sponsored by Merck & Co.. Started Dec 2002; status: completed.
02
Drugs
MK-0359
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00482235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00482235.